AzaSite^®

AzaSite (azithromycin ophthalmic solution) 1% has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of bacterial conjunctivitis, a common form of eye infection also known as "pink eye." An ocular anti-infective, AzaSite contains the drug azithromycin and is formulated with our patented DuraSite^® drug-delivery technology.

Azithromycin is a broad-spectrum antibiotic that is used to treat a variety of bacterial infections. AzaSite represents the first ophthalmic application of azithromycin. The DuraSite formulation permits prolonged antibiotic release and extended residence time in the eye. Clinical trial results have demonstrated that administration of just a few drops of AzaSite over a 5-day period provides safe and effective treatment of bacterial conjunctivitis in both children and adults.

• For information regarding the sale of AzaSite^® in the United States and Canada (Inspire Pharmaceuticals) click here.